Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis

AIM: To characterize the phenylephrine test in aponeurotic and congenital eyelid ptosis, to determine the appropriate timing of the phenylephrine test, and to assess the responses of the upper and lower eyelids. METHODS: This was a retrospective analysis of 140 eyes of 87 patients (mean age 52.29±16...

Full description

Bibliographic Details
Main Authors: Ozgun Melike Gedar Totuk, Meltem Guzin Altinel, Ayse Yagmur Kanra, Umit Aykan
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2022-09-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://ies.ijo.cn/en_publish/2022/9/20220906.pdf
_version_ 1828366447340945408
author Ozgun Melike Gedar Totuk
Meltem Guzin Altinel
Ayse Yagmur Kanra
Umit Aykan
author_facet Ozgun Melike Gedar Totuk
Meltem Guzin Altinel
Ayse Yagmur Kanra
Umit Aykan
author_sort Ozgun Melike Gedar Totuk
collection DOAJ
description AIM: To characterize the phenylephrine test in aponeurotic and congenital eyelid ptosis, to determine the appropriate timing of the phenylephrine test, and to assess the responses of the upper and lower eyelids. METHODS: This was a retrospective analysis of 140 eyes of 87 patients (mean age 52.29±16.45y; 22 males, 65 females) with upper eyelid ptosis. Totally 88.6% had aponeurotic and 11.4% had congenital ptosis. For the evaluation of the responses of the upper and lower eyelids to topical 2.5% phenylephrine, the scleral show height, the marginal reflex distance (MRD) between the inferior margin of the upper eyelid and pupillary light reflex (MRD1), and between the central portion of the lower eyelid and pupillary light reflex (MRD2) were measured at the 2nd, 5th, and 15th minutes. The changes of MRD1 and MRD2 with time (ΔMRD1 and ΔMRD2) were evaluated. RESULTS: The mean MRD1, MRD2, and scleral show heights increased within 5min after testing, remaining largely stable between the 5th-15th minutes. The percentage of eyes with a greater response in MRD1 increased with increased severity of ptosis (P<0.05). Eyes with aponeurotic ptosis were more responsive to phenylephrine testing than congenital ptosis. The mild ptosis group had lower scleral show measurements and higher ΔMRD2 values. The ΔMRD1 and ΔMRD2 values were poorly correlated in all measurement times. CONCLUSION: Performing the phenylephrine test 5min after instilling the reagent is adequate to assess the maximum response of the upper and lower eyelids. The upper and lower eyelid responses in phenylephrine testing are poorly correlated. However, the ΔMRD2 is related with baseline scleral show degree that may be a postoperative predictive factor. Further studies are necessary to determine the relationship between the responses of the lower eyelids to phenylephrine testing.
first_indexed 2024-04-14T05:45:10Z
format Article
id doaj.art-c434e033c2584f718abee226409a4d15
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-04-14T05:45:10Z
publishDate 2022-09-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-c434e033c2584f718abee226409a4d152022-12-22T02:09:19ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982022-09-011591444145210.18240/ijo.2022.09.0620220906Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosisOzgun Melike Gedar Totuk0Meltem Guzin Altinel1Ayse Yagmur Kanra2Umit Aykan3Ozgun Melike Gedar Totuk. Atakoy Dunyagoz Hospital, Atakoy 1. Kisim Mah. Rauf Orbay Cad. No.8 Bakırkoy, Istanbul 34158, Turkey. melikegedar@gmail.comDepartment of Ophthalmology, Fatih Sultan Mehmet Training and Research Hospital, Atasehir, Istanbul 34752, TurkeyDepartment of Ophthalmology, Sisli Hamidiye Etfal Training and Research Hospital, Sariyer, Istanbul 34453, TurkeyEtiler Dunyagoz Hospital, Besiktas, Istanbul 34337, TurkeyAIM: To characterize the phenylephrine test in aponeurotic and congenital eyelid ptosis, to determine the appropriate timing of the phenylephrine test, and to assess the responses of the upper and lower eyelids. METHODS: This was a retrospective analysis of 140 eyes of 87 patients (mean age 52.29±16.45y; 22 males, 65 females) with upper eyelid ptosis. Totally 88.6% had aponeurotic and 11.4% had congenital ptosis. For the evaluation of the responses of the upper and lower eyelids to topical 2.5% phenylephrine, the scleral show height, the marginal reflex distance (MRD) between the inferior margin of the upper eyelid and pupillary light reflex (MRD1), and between the central portion of the lower eyelid and pupillary light reflex (MRD2) were measured at the 2nd, 5th, and 15th minutes. The changes of MRD1 and MRD2 with time (ΔMRD1 and ΔMRD2) were evaluated. RESULTS: The mean MRD1, MRD2, and scleral show heights increased within 5min after testing, remaining largely stable between the 5th-15th minutes. The percentage of eyes with a greater response in MRD1 increased with increased severity of ptosis (P<0.05). Eyes with aponeurotic ptosis were more responsive to phenylephrine testing than congenital ptosis. The mild ptosis group had lower scleral show measurements and higher ΔMRD2 values. The ΔMRD1 and ΔMRD2 values were poorly correlated in all measurement times. CONCLUSION: Performing the phenylephrine test 5min after instilling the reagent is adequate to assess the maximum response of the upper and lower eyelids. The upper and lower eyelid responses in phenylephrine testing are poorly correlated. However, the ΔMRD2 is related with baseline scleral show degree that may be a postoperative predictive factor. Further studies are necessary to determine the relationship between the responses of the lower eyelids to phenylephrine testing.http://ies.ijo.cn/en_publish/2022/9/20220906.pdfeyelid ptosisphenylephrine testingscleral showaponeurotic ptosiscongenital ptosis.
spellingShingle Ozgun Melike Gedar Totuk
Meltem Guzin Altinel
Ayse Yagmur Kanra
Umit Aykan
Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
International Journal of Ophthalmology
eyelid ptosis
phenylephrine testing
scleral show
aponeurotic ptosis
congenital ptosis.
title Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
title_full Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
title_fullStr Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
title_full_unstemmed Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
title_short Clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
title_sort clinical value of phenylephrine testing in the upper and lower eyelids of patients with aponeurotic and congenital eyelid ptosis
topic eyelid ptosis
phenylephrine testing
scleral show
aponeurotic ptosis
congenital ptosis.
url http://ies.ijo.cn/en_publish/2022/9/20220906.pdf
work_keys_str_mv AT ozgunmelikegedartotuk clinicalvalueofphenylephrinetestingintheupperandlowereyelidsofpatientswithaponeuroticandcongenitaleyelidptosis
AT meltemguzinaltinel clinicalvalueofphenylephrinetestingintheupperandlowereyelidsofpatientswithaponeuroticandcongenitaleyelidptosis
AT ayseyagmurkanra clinicalvalueofphenylephrinetestingintheupperandlowereyelidsofpatientswithaponeuroticandcongenitaleyelidptosis
AT umitaykan clinicalvalueofphenylephrinetestingintheupperandlowereyelidsofpatientswithaponeuroticandcongenitaleyelidptosis